Cooperative Agreement U48DP006839
Award Date
9/30/24
Completion Date
9/29/29
Dollars Obligated
$1.1M
Funding Federal Agency
National Center for Immunization and Respiratory Diseases
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.323
Assistance Type
Cooperative Agreement
Place of Performance
North Carolina, USA
Similar Awards
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program provides $1,499,856.00 to the University of Rochester to implement a project titled "Trusted School Messengers Promoting Non-Mandated Vaccination." The project aims to enhance public health agencies' capacity to detect, respond to, prevent, and control known and emerging infectious diseases through...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) provides $420,998.00 to the State of North Carolina Department of Health & Human Services (NC DHHS) for the program entitled "NORTH CAROLINA'S IMMUNIZATION AND VACCINES FOR CHILDREN GRANT YEAR 1 STRENGTHENING VACCINE-PREVENTABLE DISEASE PREVENTION AND RESPONSE". The funding will support North Carolina's efforts to...
This Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program, CFDA 93.323, provides $256,291.00 to the Association of Public Health Laboratories, Inc. (APHL) from July 1, 2025 to June 30, 2030 to enhance public health laboratory capabilities and capacities. The ELC program aims to strengthen epidemiological surveillance, laboratory testing, health information systems, and cross-disciplinary...
The Centers for Disease Control and Prevention (CDC) awarded a $3,092,000.00 Cooperative Agreement to the University of North Carolina at Chapel Hill (UNC-CH) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421). The 5-year award, effective September 30, 2024, will support UNC-CH in strengthening public health infrastructure and service delivery across the United States. Key objectives include...
This federal Cooperative Agreement award, titled "ARISE COORDINATING AND COLLABORATING CENTERS FOR THE STUDY OF VACCINE HESITANCY AND UPTAKE (CDC SIP 12)", was granted by the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program. The $799,904 award, effective from September 30, 2024 to September 29, 2029, will support New York University in conducting research to enhance public health agencies'...
The University of North Carolina at Chapel Hill (UNC-CH) has been awarded a $3,000,000 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) federal grant program. The award, effective September 30, 2024 through September 29, 2029, will support the university's "PRC CORE: Center for Health Promotion and Disease Prevention" project. This cooperative agreement aims to...
The University of Massachusetts Medical School was awarded a $1,049,646 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program. This 5-year award, effective from September 30, 2024 to September 29, 2029, aims to enhance the capacity of public health agencies to effectively detect, respond to, prevent, and control known and emerging infectious disease threats. As part of this...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,050,000 Cooperative Agreement under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) to the University of Arizona. The funding supports a 5-year project to enhance vaccine uptake across the lifespan through community-based participatory research, innovative access points, and altering norms in border and rural Arizona regions. The University of Arizona has sub-awarded portions of...
This federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements program (CFDA 93.268), supports the South Carolina Department of Public Health (SCDPH) in establishing and maintaining comprehensive vaccination initiatives targeting vaccine-preventable diseases. The $233,610 award, with a period of performance from July 1, 2025, to June 30, 2030, will enable SCDPH to enhance vaccination infrastructure, improve...
The University of North Carolina at Chapel Hill was awarded a $1,349,998.00 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the federal grant program "Centers for Research and Demonstration for Health Promotion and Disease Prevention" (CFDA 93.135). The award, effective September 30, 2024 through September 29, 2029, supports the university's Cancer Prevention and Control Research Network (CPCRN) Coordinating and Collaborating Centers. Through...